Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andreas Venizelos"'
Autor:
Andreas Venizelos, Christina Engebrethsen, Wei Deng, Jürgen Geisler, Stephanie Geisler, Gjertrud T. Iversen, Turid Aas, Hildegunn S. Aase, Manouchehr Seyedzadeh, Eli Sihn Steinskog, Ola Myklebost, Sigve Nakken, Daniel Vodak, Eivind Hovig, Leonardo A. Meza-Zepeda, Per E. Lønning, Stian Knappskog, Hans P. Eikesdal
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-18 (2022)
Abstract Background Subclonal evolution during primary breast cancer treatment is largely unexplored. We aimed to assess the dynamic changes in subclonal composition of treatment-naïve breast cancers during neoadjuvant chemotherapy. Methods We perfo
Externí odkaz:
https://doaj.org/article/c8fdf6f22c9d4f50b2aecdfe0b4e304f
Autor:
Hege Elvebakken, Sönke Detlefsen, Oleksii Nikolaienko, Aurel Perren, Stian Knappskog, Inger Marie Bowitz Lothe, Anna Sundlöv, Johanna Svensson, Anne Couvelard, Wei Deng, Harrish Garresori, Andreas Venizelos, Halfdan Sorbye, Merete Krogh, Christian Kersten, Geir Olav Hjortland, Eva Hofsli
Publikováno v:
Venizelos, Andreas; Elvebakken, Hege; Perren, Aurel; Nikolaienko, Oleksii; Deng, Wei; Lothe, Inger Marie B; Couvelard, Anne; Hjortland, Geir Olav; Sundlöv, Anna; Svensson, Johanna; Garresori, Harrish; Kersten, Christian; Hofsli, Eva; Detlefsen, Sönke; Krogh, Merete; Sorbye, Halfdan; Knappskog, Stian (2021). The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer, 29(1), pp. 1-14. BioScientifica Ltd. 10.1530/ERC-21-0152
Endocrine-Related Cancer
Venizelos, A, Elvebakken, H, Perren, A, Nikolaienko, O, Deng, W, Lothe, I M B, Couvelard, A, Hjortland, G O, Sundlöv, A, Svensson, J B, Garresori, H, Kersten, C, Hofsli, E, Detlefsen, S, Krogh, M, Sorbye, H & Knappskog, S 2022, ' The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms ', Endocrine-Related Cancer, vol. 29, no. 1, pp. 1-14 . https://doi.org/10.1530/ERC-21-0152
Endocrine-Related Cancer
Venizelos, A, Elvebakken, H, Perren, A, Nikolaienko, O, Deng, W, Lothe, I M B, Couvelard, A, Hjortland, G O, Sundlöv, A, Svensson, J B, Garresori, H, Kersten, C, Hofsli, E, Detlefsen, S, Krogh, M, Sorbye, H & Knappskog, S 2022, ' The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms ', Endocrine-Related Cancer, vol. 29, no. 1, pp. 1-14 . https://doi.org/10.1530/ERC-21-0152
High-grade (HG) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) are rare but have a very poor prognosis and represent a severely understudied class of tumours. Molecular data for HG GEP-NEN are limited, and treatment strategies for the ca
Autor:
Johanna Svensson, Inger Marie Bowitz Lothe, Stian Knappskog, Christian Kersten, Halfdan Sorbye, Anna Sundlöv, Andreas Venizelos, Geir Olav Hjortland, Merete Krogh, Sönke Detlefsen, Hege Elvebakken, Aurel Perren, H. Garresori
Publikováno v:
Annals of Oncology. 32:S910-S911
Autor:
Helge Espelid, Stian Knappskog, Alba Llop-Guevara, Judith Balmaña, Beryl Leirvaag, Jürgen Geisler, Bjørnar Gilje, Laura Minsaas, Asmaa Elzawahry, Steinar Lundgren, Olav Karsten Vintermyr, Egil S. Blix, Per Eystein Lønning, Synnøve Yndestad, Geirfinn Vagstad, Emiel A. M. Janssen, Hildegunn Siv Aase, Andreas Venizelos, Hans Petter Eikesdal, Violeta Serra, Einar Gudlaugsson, Turid Aas
Publikováno v:
Annals of Oncology
Background The antitumor efficacy of PARP inhibitors (PARPi) for breast cancer patients harboring germline BRCA1/2 (gBRCA1/2) mutations is well established. While PARPi monotherapy was ineffective in patients with metastatic triple negative breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71c4233c7a23662c06d637156987fe9c
https://hdl.handle.net/10037/20445
https://hdl.handle.net/10037/20445
Autor:
Inger Marie Loees, Hans Petter Eikesdal, Per Eystein Lønning, Andreas Venizelos, Stian Knappskog
Publikováno v:
Cancer Research. 79:2507-2507
Resistance to chemotherapy remains a main cause of death among cancer patients. The primary aim of the present study was to identify genetic alterations predicting resistance to chemotherapy by whole exome sequencing (WES) of tumors subject to neoadj